161 related articles for article (PubMed ID: 30658059)
1. Duodenal-jejunal lining increases postprandial unconjugated bile acid responses and disrupts the bile acid-FXR-FGF19 axis in humans.
van Nierop FS; de Jonge C; Kulik W; Bouvy N; Schaap FG; Olde Damink SW; Rensen S; Romijn JA; Greve JWM; Soeters MR
Metabolism; 2019 Apr; 93():25-32. PubMed ID: 30658059
[TBL] [Abstract][Full Text] [Related]
2. Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus.
Kaválková P; Mráz M; Trachta P; Kloučková J; Cinkajzlová A; Lacinová Z; Haluzíková D; Beneš M; Vlasáková Z; Burda V; Novák D; Petr T; Vítek L; Pelikánová T; Haluzík M
J Endocrinol; 2016 Oct; 231(1):11-22. PubMed ID: 27474690
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of a 40-hour fast and bile acid supplementation on human GLP-1 and FGF19 responses.
van Nierop FS; Meessen ECE; Nelissen KGM; Achterbergh R; Lammers LA; Vaz FM; Mathôt RAA; Klümpen HJ; Olde Damink SW; Schaap FG; Romijn JA; Kemper EM; Soeters MR
Am J Physiol Endocrinol Metab; 2019 Sep; 317(3):E494-E502. PubMed ID: 31237451
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.
de Jonge C; Rensen SS; Verdam FJ; Vincent RP; Bloom SR; Buurman WA; le Roux CW; Schaper NC; Bouvy ND; Greve JW
Obes Surg; 2013 Sep; 23(9):1354-60. PubMed ID: 23526068
[TBL] [Abstract][Full Text] [Related]
5. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
Rohde U
Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
[TBL] [Abstract][Full Text] [Related]
6. Duodenal mucosal resurfacing with a GLP-1 receptor agonist increases postprandial unconjugated bile acids in patients with insulin-dependent type 2 diabetes.
Meiring S; Meessen ECE; van Baar ACG; Holleman F; Nieuwdorp M; Olde Damink SW; Schaap FG; Vaz FM; Groen AK; Soeters MR; Bergman JJGHM
Am J Physiol Endocrinol Metab; 2022 Feb; 322(2):E132-E140. PubMed ID: 34957857
[TBL] [Abstract][Full Text] [Related]
7. Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
Stratmann B; Krepak Y; Schiffer E; Jarick I; Hauber M; Lee-Barkey YH; Fischer M; Tschoepe D
Horm Metab Res; 2016 Sep; 48(10):630-637. PubMed ID: 27589345
[TBL] [Abstract][Full Text] [Related]
8. Effects of Duodenal-Jejunal Exclusion and New Bilio-Pancreatic Diversion on Blood Glucose in Rats with Type 2 Diabetes Mellitus.
Weng SG; Zhang B; Wang X; Chen H
Obes Surg; 2017 Aug; 27(8):2067-2072. PubMed ID: 28233263
[TBL] [Abstract][Full Text] [Related]
9. Measures of glucose homeostasis during and after duodenal exclusion using a duodenal-jejunal bypass liner in a normoglycemic, nonobese canine model.
Paszkiewicz RL; Burch MA; Asare Bediako I; Mkrtchyan H; Piccinini F; Ader M; Bresee C; Bergman RN
Surg Obes Relat Dis; 2022 Jun; 18(6):694-702. PubMed ID: 35361540
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of Bile Acid Profiles, GLP-1, and FGF19 After Laparoscopic Gastric Banding.
Thöni V; Pfister A; Melmer A; Enrich B; Salzmann K; Kaser S; Lamina C; Ebenbichler CF; Hackl H; Tilg H; Moschen AR
J Clin Endocrinol Metab; 2017 Aug; 102(8):2974-2984. PubMed ID: 28591793
[TBL] [Abstract][Full Text] [Related]
11. Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes.
Jirapinyo P; Haas AV; Thompson CC
Diabetes Care; 2018 May; 41(5):1106-1115. PubMed ID: 29678867
[TBL] [Abstract][Full Text] [Related]
12. Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes.
Calderon G; McRae A; Rievaj J; Davis J; Zandvakili I; Linker-Nord S; Burton D; Roberts G; Reimann F; Gedulin B; Vella A; LaRusso NF; Camilleri M; Gribble FM; Acosta A
EBioMedicine; 2020 May; 55():102759. PubMed ID: 32344198
[TBL] [Abstract][Full Text] [Related]
13. The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance.
Yan X; Li P; Tang Z; Feng B
BMC Endocr Disord; 2017 Sep; 17(1):60. PubMed ID: 28946907
[TBL] [Abstract][Full Text] [Related]
14. A Preclinical Animal Study of Combined Intragastric Balloon and Duodenal-Jejunal Bypass Liner for Obesity and Metabolic Disease.
Ghoz H; Jaruvongvanich V; Matar R; Beran A; Maselli DB; Storm AC; Abu Dayyeh BK
Clin Transl Gastroenterol; 2020 Sep; 11(9):e00234. PubMed ID: 33094961
[TBL] [Abstract][Full Text] [Related]
15. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.
Koehestanie P; de Jonge C; Berends FJ; Janssen IM; Bouvy ND; Greve JW
Ann Surg; 2014 Dec; 260(6):984-92. PubMed ID: 25072436
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study.
Laubner K; Riedel N; Fink K; Holl RW; Welp R; Kempe HP; Lautenbach A; Schlensak M; Stengel R; Eberl T; Dederichs F; Schwacha H; Seufert J; Aberle J
Diabetes Obes Metab; 2018 Aug; 20(8):1868-1877. PubMed ID: 29569313
[TBL] [Abstract][Full Text] [Related]
17. Effects of acute dietary weight loss on postprandial plasma bile acid responses in obese insulin resistant subjects.
van Nierop FS; Kulik W; Endert E; Schaap FG; Olde Damink SW; Romijn JA; Soeters MR
Clin Nutr; 2017 Dec; 36(6):1615-1620. PubMed ID: 27773549
[TBL] [Abstract][Full Text] [Related]
18. The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study.
van Rijn S; Betzel B; de Jonge C; van Dijk DPJ; Janssen IM; Berends FJ; Bouvy ND; Greve JWM
Obes Surg; 2018 May; 28(5):1255-1262. PubMed ID: 29110244
[TBL] [Abstract][Full Text] [Related]
19. Influence of glucometric 'dynamical' variables on duodenal-jejunal bypass liner (DJBL) anthropometric and metabolic outcomes.
Colás A; Varela M; Mraz M; Novak D; Cuesta-Frau D; Vigil L; Benes M; Pelikanova T; Haluzik M; Burda V; Vargas B
Diabetes Metab Res Rev; 2020 May; 36(4):e3287. PubMed ID: 31916665
[TBL] [Abstract][Full Text] [Related]
20. Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients.
Sonne DP; Hare KJ; Martens P; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(4):G413-9. PubMed ID: 23275610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
